Clinical Trial Update: Study to Assess Efficacy and Safety of M72/AS01E-4 Mycobacterium Tuberculosis (Mtb) Vaccine in Adolescents and Adults [Phase 3]

View source ↗

Summary

A Phase 3 trial update for the M72/AS01E vaccine in adolescents and adults evaluating efficacy and safety for tuberculosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• M72/AS01E (M72/AS01E)

Snippet

Sponsor: Gates Medical Research Institute | Conditions: Tuberculosis | Phase 3 | Status: ACTIVE_NOT_RECRUITING